Matthew Plunkett - Apollomics Chief Officer
| APLM Stock | 6.70 0.50 8.06% |
Executive
Matthew Plunkett is Chief Officer of Apollomics Class A
| Age | 53 |
| Address | 989 East Hillsdale Blvd, Foster City, CA, United States, 94404 |
| Phone | 650 209 4055 |
| Web | https://www.apollomicsinc.com |
Apollomics Management Efficiency
The company has return on total asset (ROA) of (0.6274) % which means that it has lost $0.6274 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4931) %, meaning that it created substantial loss on money invested by shareholders. Apollomics' management efficiency ratios could be used to measure how well Apollomics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of March 2025, Return On Tangible Assets is likely to grow to -4.64. In addition to that, Return On Capital Employed is likely to drop to -1.58. At this time, Apollomics' Total Assets are very stable compared to the past year. As of the 3rd of March 2025, Non Current Assets Total is likely to grow to about 19.9 M, while Other Current Assets are likely to drop about 1.3 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Laurie Grijalva | Boot Barn Holdings | 67 | |
| Mikael Larsen | Torm PLC Class | N/A | |
| Noah Brodsky | Lindblad Expeditions Holdings | 44 | |
| Jesper Jensen | Torm PLC Class | 56 | |
| Dione Rigsby | Nexstar Broadcasting Group | 53 | |
| Blake Russell | Nexstar Broadcasting Group | 54 | |
| Juliusz Komorek | Ryanair Holdings PLC | 47 | |
| Lindsey Harmon | Nexstar Broadcasting Group | N/A | |
| John Tuite | Ryanair Holdings PLC | N/A | |
| Alexis Freeman | Lindblad Expeditions Holdings | N/A | |
| Gary Weitman | Nexstar Broadcasting Group | 68 | |
| Jerry Walsh | Nexstar Broadcasting Group | N/A | |
| Terri Bush | Nexstar Broadcasting Group | N/A | |
| Carol Sharkey | Ryanair Holdings PLC | 49 | |
| Lars Christensen | Torm PLC Class | 59 | |
| Michal Kaczmarzyk | Ryanair Holdings PLC | 45 | |
| Rick Goldberg | Lindblad Expeditions Holdings | N/A | |
| Jonathon Kosoff | Boot Barn Holdings | 47 | |
| Jacinta McEvoy | Lindblad Expeditions Holdings | N/A | |
| Michael Strober | Nexstar Broadcasting Group | 55 | |
| Lindsey Knapp | Nexstar Broadcasting Group | N/A | |
Management Performance
| Return On Equity | -1.49 | ||||
| Return On Asset | -0.63 |
Apollomics Class A Leadership Team
Elected by the shareholders, the Apollomics' board of directors comprises two types of representatives: Apollomics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apollomics. The board's role is to monitor Apollomics' management team and ensure that shareholders' interests are well served. Apollomics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apollomics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sanjeev MBA, President CoFounder | ||
| GuoLiang Yu, CEO CoFounder | ||
| Matthew Plunkett, Chief Officer | ||
| Chinglin Lai, Senior Management | ||
| KinHung MD, Chief Officer | ||
| Lijuan Wang, Chief China |
Apollomics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apollomics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.49 | ||||
| Return On Asset | -0.63 | ||||
| Operating Margin | (14.32) % | ||||
| Current Valuation | (14.37 M) | ||||
| Shares Outstanding | 110.27 M | ||||
| Shares Owned By Insiders | 47.32 % | ||||
| Shares Owned By Institutions | 2.08 % | ||||
| Number Of Shares Shorted | 6.94 K | ||||
| Price To Book | 0.33 X | ||||
| Price To Sales | 3.25 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apollomics Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apollomics. If investors know Apollomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apollomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share | Quarterly Revenue Growth 2.623 | Return On Assets | Return On Equity |
The market value of Apollomics Class A is measured differently than its book value, which is the value of Apollomics that is recorded on the company's balance sheet. Investors also form their own opinion of Apollomics' value that differs from its market value or its book value, called intrinsic value, which is Apollomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apollomics' market value can be influenced by many factors that don't directly affect Apollomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apollomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Apollomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apollomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.